SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Pliant Therapeutics, Inc. – IPO: ‘S-1/A’ on 5/26/20 – ‘EX-4.1’

On:  Tuesday, 5/26/20, at 6:14am ET   ·   Accession #:  1193125-20-150643   ·   File #:  333-238146

Previous ‘S-1’:  ‘S-1’ on 5/11/20   ·   Next & Latest:  ‘S-1/A’ on 6/2/20   ·   27 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/26/20  Pliant Therapeutics, Inc.         S-1/A                 11:10M                                    Donnelley … Solutions/FA

Initial Public Offering (IPO):  Pre-Effective Amendment to Registration Statement (General Form)   —   Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1/A       Pre-Effective Amendment to Registration Statement   HTML   1.81M 
                (General Form)                                                   
 2: EX-1.1      Underwriting Agreement                              HTML    148K 
 3: EX-3.1.1    Articles of Incorporation/Organization or Bylaws    HTML     11K 
 4: EX-3.2      Articles of Incorporation/Organization or Bylaws    HTML     24K 
 5: EX-3.4      Articles of Incorporation/Organization or Bylaws    HTML     88K 
 6: EX-4.1      Instrument Defining the Rights of Security Holders  HTML     19K 
 7: EX-5.1      Opinion of Counsel re: Legality                     HTML      8K 
 8: EX-10.2     Material Contract                                   HTML    200K 
 9: EX-10.3     Material Contract                                   HTML     36K 
10: EX-10.6     Material Contract                                   HTML     16K 
11: EX-23.1     Consent of Experts or Counsel                       HTML      6K 


‘EX-4.1’   —   Instrument Defining the Rights of Security Holders


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  EX-4.1  

Exhibit 4.1

 

LOGO

ZQ|CERT#|COY|CLS|RGSTRY|ACCT#|TRANSTYPE|RUN#|TRANS#
COMMON STOCK COMMON STOCK
PAR VALUE $0.0001
Certificate Shares
Number * * 000000 ******************
* * * 000000 *****************
ZQ00000000
**** 000000 ****************
PLIANT THERAPEUTICS, INC. ***** 000000 *************** ****** 000000 **************
INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE
** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample SEE REVERSE FOR CERTAIN DEFINITIONS
**** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander David THIS CERTIFIES THAT Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr
MR. Alexander.David SAMPLE Sample **** Mr. Alexander David &Sample MRS **** Mr. Alexander . SAMPLE David Sample **** Mr. Alexander & David Sample **** Mr.
Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr Alexander David Sample **** Mr. Alexander David Sample **** CUSIP XXXXXX XX X Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander MR David Sample . SAMPLE **** Mr. Alexander David Sample **** &Mr . Alexander MRS David Sample . SAMPLE **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr.
Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Sample **** Mr. Sample
is the owner of **000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares*** *000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****
000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****0 THIS CERTIFICATE IS TRANSFERABLE IN 00000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****00 ***ZERO-HUNDRED THOUSAND
0000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000 CITIES DESIGNATED BY THE TRANSFER 000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****0000 AGENT, AVAILABLE ONLINE AT 00**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****00000 0**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000 ZERO HUNDRED AND ZERO*** www.computershare.com **Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000* *Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000** Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**S
FULLY-PAID AND NON-ASSESSABLE SHARES OF COMMON STOCK OF
Pliant Therapeutics, Inc. (hereinafter called the “Company”), transferable on the books of the Company in person or by duly authorized attorney, upon surrender of this Certificate properly endorsed. This Certificate and the shares represented hereby, are issued and shall be held subject to all of the provisions of the Cetificate of Incorporation, as amended, and the By-Laws, as amended, of the Company (copies of which are on file with the Company and with the Transfer Agent), to all of which each holder, by acceptance hereof, assents. This Certificate is not valid unless countersigned and registered by the Transfer Agent and Registrar.
Witness the facsimile seal of the Company and the facsimile signatures of its duly authorized officers.
DATED DD-MMM-YYYY
RAPE
FACSIMILE SIGNATURE TO COME E U COUNTERSIGNED AND REGISTERED:
H TI
T POR
R A C COMPUTERSHARE TRUST COMPANY, N.A.
T CO TE S
N , TRANSFER-AGENT AND-REGISTRAR, President A I
L I N
P . C
June 8, 2015
DEL RE
FACSIMILE SIGNATURE TO COME AWA
By
Secretary AUTHORIZED - SIGNATURE
CUSIP/IDENTIFIER XXXXXX XX X
Holder ID XXXXXXXXXX
Insurance Value 1,000,000.00 Number of Shares 123456
DTC 12345678 123456789012345
PO BOX 505006, Louisville, KY 40233-5006
Certificate Numbers Num/No. Denom. Total
MR A SAMPLE 1234567890/1234567890 1 1 1 DESIGNATION (IF ANY) 1234567890/1234567890 2 2 2
ADD 1
ADD 2 1234567890/1234567890 3 3 3 1234567890/1234567890 4 4 4
ADD 3
ADD 4 1234567890/1234567890 5 5 5 1234567890/1234567890 6 6 6
Total Transaction 7


 

LOGO

The IRS requires that the named transfer agent (“we”) report the cost
basis of certain shares or units acquired after January 1, 2011. If your
shares or units are covered by the legislation, and you requested to sell
or transfer the shares or units using a specific cost basis calculation
method, then we have processed as you requested. If you did not
specify a cost basis calculation method, then we have defaulted to the
first in, first out (FIFO) method. Please consult your tax advisor if you
need additional information about cost basis.
If you do not keep in contact with the issuer or do not have any
activity in your account for the time period specified by state law,
your property may become subject to state unclaimed property
laws and transferred to the appropriate state.
For value received, ____________________________hereby sell, assign and transfer unto
Shares
Attorney
Dated: __________________________________________20__________________
Signature: ____________________________________________________________
Signature: ____________________________________________________________
Notice: The signature to this assignment must correspond with the name
as written upon the face of the certificate, in every particular,
without alteration or enlargement, or any change whatever.
PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER OF ASSIGNEE
(PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS, INCLUDING POSTAL ZIP CODE, OF ASSIGNEE)
of the common stock represented by the within Certificate, and do hereby irrevocably constitute and appoint
to transfer the said stock on the books of the within-named Company with full power of substitution in the premises.
.
PLIANT THERAPEUTICS, INC.
THE COMPANY WILL FURNISH WITHOUT CHARGE TO EACH SHAREHOLDER WHO SO REQUESTS, A SUMMARY OF THE POWERS, DESIGNATIONS,
PREFERENCES AND RELATIVE, PARTICIPATING, OPTIONAL OR OTHER SPECIAL RIGHTS OF EACH CLASS OF STOCK OF THE COMPANY AND THE
QUALIFICATIONS, LIMITATIONS OR RESTRICTIONS OF SUCH PREFERENCES AND RIGHTS, AND THE VARIATIONS IN RIGHTS, PREFERENCES AND
LIMITATIONS DETERMINED FOR EACH SERIES, WHICH ARE FIXED BY THE CERTIFICATE OF INCORPORATION OF THE COMPANY, AS AMENDED, AND
THE RESOLUTIONS OF THE BOARD OF DIRECTORS OF THE COMPANY, AND THE AUTHORITY OF THE BOARD OF DIRECTORS TO DETERMINE
VARIATIONS FOR FUTURE SERIES. SUCH REQUEST MAY BE MADE TO THE OFFICE OF THE SECRETARY OF THE COMPANY OR TO THE TRANSFER
AGENT. THE BOARD OF DIRECTORS MAY REQUIRE THE OWNER OF A LOST OR DESTROYED STOCK CERTIFICATE, OR HIS LEGAL
REPRESENTATIVES, TO GIVE THE COMPANY A BOND TO INDEMNIFY IT AND ITS TRANSFER AGENTS AND REGISTRARS AGAINST ANY CLAIM THAT
MAY BE MADE AGAINST THEM ON ACCOUNT OF THE ALLEGED LOSS OR DESTRUCTION OF ANY SUCH CERTIFICATE.
Signature(s) Guaranteed: Medallion Guarantee Stamp
THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (Banks,
Stockbrokers, Savings and Loan Associations and Credit Unions) WITH MEMBERSHIP IN AN APPROVED
SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15.
The following abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they were written out in full
according to applicable laws or regulations:
TEN COM - as tenants in common UNIF GIFT MIN ACT - ............................................Custodian .................................................
(Cust) (Minor)
TEN ENT - as tenants by the entireties under Uniform Gifts to Minors Act ........................................................
(State)
JT TEN - as joint tenants with right of survivorship UNIF TRF MIN ACT - ............................................Custodian (until age ................................)
and not as tenants in common (Cust)
.............................under Uniform Transfers to Minors Act ...................
(Minor) (State)
Additional abbreviations may also be used though not in the above list.


Dates Referenced Herein

This ‘S-1/A’ Filing    Date    Other Filings
Filed on:5/26/20None on these Dates
6/8/15
1/1/11
 List all Filings 


27 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/06/24  Pliant Therapeutics, Inc.         10-Q        3/31/24   82:6.6M
 2/27/24  Pliant Therapeutics, Inc.         S-8         2/27/24    4:104K
 2/27/24  Pliant Therapeutics, Inc.         10-K       12/31/23   97:13M
11/09/23  Pliant Therapeutics, Inc.         10-Q        9/30/23   78:6M
 8/09/23  Pliant Therapeutics, Inc.         10-Q        6/30/23   72:5.5M
 5/09/23  Pliant Therapeutics, Inc.         10-Q        3/31/23   78:6.1M
 3/27/23  Pliant Therapeutics, Inc.         S-3ASR      3/27/23    4:622K                                   Donnelley … Solutions/FA
 3/09/23  Pliant Therapeutics, Inc.         S-8         3/09/23    4:88K                                    Donnelley … Solutions/FA
11/08/22  Pliant Therapeutics, Inc.         10-Q        9/30/22   84:7M
 8/08/22  Pliant Therapeutics, Inc.         10-Q        6/30/22   85:6.5M
 7/11/22  Pliant Therapeutics, Inc.         POS EX      7/11/22    2:79K                                    Donnelley … Solutions/FA
 5/09/22  Pliant Therapeutics, Inc.         10-Q        3/31/22   81:5.7M
 3/01/22  Pliant Therapeutics, Inc.         10-K/A     12/31/21    4:71K                                    Donnelley … Solutions/FA
 3/01/22  Pliant Therapeutics, Inc.         S-8         3/01/22    4:87K                                    Donnelley … Solutions/FA
 3/01/22  Pliant Therapeutics, Inc.         POS AM                 3:524K                                   Donnelley … Solutions/FA
 2/28/22  Pliant Therapeutics, Inc.         POSASR      2/28/22    4:538K                                   Donnelley … Solutions/FA
11/09/21  Pliant Therapeutics, Inc.         10-Q        9/30/21   74:6.6M
 8/13/21  AbCellera Biologics Inc.          10-Q        6/30/21   62:7.9M                                   ActiveDisclosure/FA
 8/09/21  Pliant Therapeutics, Inc.         10-Q        6/30/21   75:6.4M
 7/02/21  Pliant Therapeutics, Inc.         S-3ASR      7/02/21    7:1.2M                                   Donnelley … Solutions/FA
 5/14/21  AbCellera Biologics Inc.          10-Q        3/31/21   62:6.1M                                   ActiveDisclosure/FA
 5/10/21  Pliant Therapeutics, Inc.         10-Q        3/31/21   75:5.9M
 3/30/21  AbCellera Biologics Inc.          10-K       12/31/20    8:11M                                    ActiveDisclosure/FA
 3/16/21  Pliant Therapeutics, Inc.         10-K       12/31/20   84:14M                                    ActiveDisclosure/FA
 3/16/21  Pliant Therapeutics, Inc.         S-8         3/16/21    3:67K                                    Donnelley … Solutions/FA
11/10/20  Pliant Therapeutics, Inc.         10-Q        9/30/20   81:10M                                    ActiveDisclosure/FA
 8/11/20  Pliant Therapeutics, Inc.         10-Q        6/30/20   81:9.7M                                   ActiveDisclosure/FA
Top
Filing Submission 0001193125-20-150643   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 15, 9:11:53.3pm ET